A decade of work comes to fruition. Better care for our patients with high risk prostate cancer. Both primary endpoints positive. Congrats to the entire team and recognition to all our patients who participated @MGHUrology@MassGenBrigham@MGBUrology@DanaFarber_GU
➡️ Consider targeted PC screening for LS patients & MMR testing for LS patients with PC
Limitations: sample size from 1 academic institution (reach out if you have similar cohorts & want to collaborate!)
Special thanks to collaborators @MGHUrology@MGBpathology @MGHCancerCenter
Excited to share our latest publication on prostate cancer risk in Lynch syndrome @EurUrolOpen
✨Led by all-stars Linda Rodgers-Fouché (cancer genetic counselor) and @KamkariNick (med student & current urology residency applicant)
https://t.co/VtHFQYIfLp
🛠️38% of tumors were DNA mismatch repair deficient (dMMR), remaining tumors were likely *incidental* to Lynch germline pathogenic variant
⚠️dMMR tumors were higher risk (71% NCCN UIR/High-Risk vs 0% FIR/Low-Risk)
🧬No dMMR tumors in MLH1 or PMS2 PV carriers
Thrilled to join JCO PO as Associate Editor! Excited to contribute to the journal's important work in disseminating high-quality cancer research. @JCOPO_ASCO
Please join for Virtual Open House on Tues Dec 17th, 7:30-8:30pm EST for the Combined Harvard Medical School Urologic Oncology Fellowship
@MGHUrology
@BWHUrology
Meet fellows, residents, faculty in an open setting.
Please use Zoom link: https://t.co/CscfGPz2jX
@SUO_YUO@UroOnc
Join us Nov 1 for the one-day CME course, “State of the Art Imaging in the Diagnosis and Management of Prostate Cancer” featuring advances in mpMRI, MRI-US fusion biopsy, PSMA PET imaging, and more.
To register:
https://t.co/X2AEkHHmzm
🔔Education Opportunity for Patients with #ProstateCancer & Their Families
📆 5/17/24 8amEST (virtual)
Here from experts discussing
✴️ Diet/Lifestyle 🚴♂️
✴️ AI 🤖
✴️ Biochemical Recurrence 📈
✴️ Genetics 🧬
✴️ Survivorship ☺️
Register for FREE! ✍🏽
Link: https://t.co/xkF4emlXiZ
@CGM_MGH associate member and @MGHUrology faculty @KeyanSalari & colleagues find integration of family history + germline genetics refines risk stratification to help individualize prostate cancer care. More here: https://t.co/GA6Fz18BGN
Now published in @EurUrolOncol by @KeyanSalari@aethridgeamini et al: MRI-based Prostate Cancer Screening in Carriers of Pathogenic Germline Mutations: Interim Results from the Initial Screening Round of PROGRESS @MGHUrology @MGHCancerCenter https://t.co/l2S6ES2O8a
Now published in @JCOPO_ASCO by @MGHUrology@KeyanSalari and incoming urology resident @aethridgeamini: Incorporating Genetic Risk Into Prostate Cancer Care: Implications for Early Detection and Precision Oncology https://t.co/pGECK9rSwK
@MGHUrology is looking to hire urologists to treat benign urologic conditions. Those with interest in general urology, endourology/urolithiasis/BPH, reconstructive urology, FMPRS, andrology/infertility please see link below!
https://t.co/BTdA9yL9F1